New data from two reports, published on 7 May by EFPIA, highlight the ongoing challenges of providing equal access to medicines for all Europeans.  

Part of EFPIA’s ongoing commitment to build data on access and availability of medicines in Europe, the Patients W.A.I.T. Indicator shows persistent, significant variation in access to new medicines between countries across the EU, while the CRA Report on the Root Causes of Unavailability and Delay to Innovative Medicines identifies the numerous interlinked reasons behind the delays and barriers that patients face.